Clinical Trials Sponsored by Mark Weston

Total 8023 results

Roswell Park Cancer Institute

Terminated

Guided Biopsy for Mapping Prostate Cancer (HIT)

Prostate Cancer

United States
Roswell Park Cancer Institute

Withdrawn

Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia

Refractory Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute

Completed

Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute

Completed

Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute

Withdrawn

Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance

Prostate Cancer
Roswell Park Cancer Institute

Completed

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm

United States
Roswell Park Cancer Institute

Completed

Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

Prostate Cancer

United States
Roswell Park Cancer Institute

Completed

Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum

Colorectal Cancer

United States
Roswell Park Cancer Institute

Completed

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

Head and Neck Cancer

United States
Roswell Park Cancer Institute

Terminated

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

Multiple Myeloma and Plasma Cell Neoplasm

United States
Roswell Park Cancer Institute

Terminated

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
Medical Park Gaziantep Hospital

Completed

Laparoscopic Versus Open Surgery for the Management of Cystic Echinococcosis of the Liver

Echinococcosis, Hepatic | Hydatid Cyst

Turkey
Roswell Park Cancer Institute

Withdrawn

Study for Determination of Feasibility and Toxicity of Pre-Treatment With HPPH (2-1[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a) Photodynamic Therapy Prior to Chemoradiation in Non-Operable Patients With Obstructive Esophageal Cancer

Esophageal Neoplasm
Roswell Park Cancer Institute

Completed

Photodynamic Therapy in Treating Patients With Early Esophageal Cancer

Esophageal Cancer

United States
Roswell Park Cancer Institute

Completed

Irinotecan and Capecitabine in Treating Women With Advanced Breast Cancer

Breast Cancer

United States
Roswell Park Cancer Institute

Completed

Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors

Esophageal Cancer

United States
Roswell Park Cancer Institute

Completed

Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract

Graft Versus Host Disease

United States
Roswell Park Cancer Institute

Completed

Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery

Lung Cancer

United States
Roswell Park Cancer Institute

Completed

Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute

Completed

Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
Roswell Park Cancer Institute

Completed

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Neuroblastoma | Graft Versus Host Disease

United States
Roswell Park Cancer Institute

Completed

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Graft Versus Host Disease

United States
Roswell Park Cancer Institute

Completed

Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
Roswell Park Cancer Institute

Completed

Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma

Malignant Mesothelioma

United States
Roswell Park Cancer Institute

Completed

Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer

Lymphoma | Brain and Central Nervous System Tumors | Neuroblastoma | Retinoblastoma

United States
Roswell Park Cancer Institute

Completed

Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy

Pain | Prostate Cancer

United States
Duk-Woo Park, MD
Boston Scientific Corporation; CardioVascular Research Foundation, Korea

Recruiting

The Sentinel Registry (Sentinel)

Aortic Valve Disease | Transcatheter Aortic Valve Replacement | Transcatheter Aortic Valve Implantation

Korea, Republic of
Mark M. Fuster, MD

Withdrawn

Early Diagnosis and Treatment of Sleep Disordered Breathing in Lung Cancer

Lung Cancer

United States
Mark Pegram
United States Department of Defense

Terminated

Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption

Breast Cancer | Bone Diseases

United States
Mark Lebwohl

Completed

Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)

Pseudoxanthoma Elasticum

United States
Ark Biosciences Inc.
Shanghai Ark Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

China
Hospital del Mar

Not yet recruiting

External Validation os the ACME Scoring System (ACME_2)

Acute Cholecystitis
Hospital del Mar

Not yet recruiting

Critical Analysis of the Results in the Management of Penetrating Abdominal Trauma in the Past Fifteen Years. (PAT-HMAR)

Penetrating Abdominal Trauma
Hospital del Mar

Not yet recruiting

From Great Surgeons to Brilliant Observators, Evolution of Penetrating Neck Trauma in a Single Center Reference in Spain (PNT-HMAR)

Penetrating Neck Trauma
Hospital del Mar

Not yet recruiting

Prospective Registry of Patients With Pancreas Adenocarcinoma Resectable and Borderline (PaNLoCat)

Chemotherapy Effect | Pancreas Cancer

Spain
Hospital del Mar

Not yet recruiting

"Suture of the Tuberosities in Inverted Prostheses" Implanted for Acute Fractures of the Proximal Humerus?.

Proximal Humeral Fractures, Reverse Shoulder Prostheses, Tuberosities
Hospital del Mar

Recruiting

NaROA STUDY: National Register of Open Abdomen (NaROA)

Open Abdomen Technique

Spain
Hospital del Mar

Completed

Lateral Retinacular Release in Total Knee Arthroplasty With Patellar Replacement

Anterior Knee Pain Syndrome

Spain
Ark Biosciences Inc.

Completed

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Ziresovir in Healthy Subjects

Healthy Subjects

United States
Ark Biosciences Inc.

Completed

A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects

Healthy

Sweden
Hospital del Mar

Unknown

Application of MRI for Musculoskeletal Involvement in SLE (RMNLES)

Hand Rheumatism | Systemic Lupus Erythematosus Arthritis

Spain
Hospital del Mar

Completed

Conservative Treatment of Proximal Humeral Fractures

Shoulder Fractures

Spain
Ark Biosciences Inc.

Terminated

A Study of AK0529 in Infants Hospitalized With RSV

Respiratory Syncytial Virus Infections

Australia
Ark Biosciences Inc.

Completed

Safety, Tolerability and PK Study of AK0529 in Healthy Human

Respiratory Syncytial Virus Infections

Australia
Ark Therapeutics Ltd

Terminated

Adenovirus Vascular Endothelial Growth Factor (VEGF) Therapy in Vascular Access - Novel Trinam AGainst Control Evidence (AdV-VANTAGE)

End Stage Renal Disease

United States
Mark Evers
National Cancer Institute (NCI)

Recruiting

TVB 2640 for Resectable Colon Cancer Other Resectable Cancers; a Window Trial.

Colon Cancer

United States
Mark Swanson, PhD
Community Farm Alliance

Completed

Appalachians Together Restoring the Eating Environment (Appal-TREE)

Dietary Habits

United States
Mark Frye
University of California, Los Angeles

Withdrawn

Can Additional Drug Therapy Accelerate Response Time to Antidepressants

Depression

United States
NBTY, Inc.
KGK Science Inc.; Moyad, Mark MD MPH

Completed

Tolerance of Two Forms of Vitamin C in Acid-sensitive Adults

Tolerance

Canada
NBTY, Inc.
KGK Science Inc.; Moyad, Mark MD MPH

Completed

Comparative Bioavailability of Two Forms of Vitamin C

Bioavailability

Canada

Clinical Trials Sponsored by Mark Weston

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations